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Background: Uric acid has been reported to function both as an oxidant or antioxidant depending on the context. 
A previous study in the Korean population reported a positive linear association between serum uric acid level and 
arterial stiffness in men, but little is known about how serum uric acid level is related to the risk of increased arterial 
stiffness in Korean postmenopausal women.
Methods: We performed a cross-sectional study of 293 subjects who participated in a health examination program 
run by the health promotion center of Gangnam Severance Hospital between October 2007 and July 2010. High 
brachial-ankle pulse wave velocity was defined as a brachial-ankle pulse wave velocity of more than 1,450 cm/s. 
The odds ratios (ORs) for high brachial-ankle pulse wave velocity were calculated using multivariate logistic regres-
sion analysis across uric acid quartiles after adjusting for other indicators of cardiovascular risk.
Results: The 293 postmenopausal women were divided into quartiles according to uric acid level. The mean bra-
chial-ankle pulse wave velocity values of each quartile were as follows: Q1, 1,474 cm/s; Q2, 1,375 cm/s; Q3, 1,422 
cm/s; Q4, 1,528 cm/s. The second quartile was designated as the control group based on mean brachial-ankle 
pulse wave velocity value. Multivariate adjusted ORs (95% confidence intervals) for brachial-ankle pulse wave ve-
locity across the uric acid quartiles were 2.642 (Q1, 1.095–6.3373), 1.00, 4.305 (Q3, 1.798–10.307), and 4.375 (Q4, 
1.923–9.949), after adjusting for confounding variables.
Conclusion: Serum uric acid level has a J-shaped association with arterial stiffness in Korean postmenopausal 
women.
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INTRODUCTION
In human, uric acid is a by-product of purine metabolism, and can 
function as an oxidant or antioxidant.1,2-7) A previous study reported a 
positive association between a high serum uric acid level in the nor-
mal range and increased arterial stiffness.2) Furthermore, high serum 
uric acid level could be a risk factor for metabolic syndrome.7,8) Hakoda 
et al.9) examined serum uric acid concentration as a risk factor for car-
diovascular mortality, and found that a high serum uric acid level was 
associated with cardiovascular mortality.7) However, it is not clear how 
serum uric acid increases oxidative stress or contributes to chronic 
diseases, such as metabolic and cardiovascular disease in men, and 
few studies have investigated the associations between low serum uric 
acid levels and arterial stiffness.10)
 Arterial stiffness can be easily measured by examining the brachial-
ankle pulse wave velocity (ba-PWV), which is a significant predictor of 
cardiovascular events and metabolic disease.11-13) Recently, a simple 
automated device has become available for the measurement of ba-
PWV using a volume-rendering method.13)
 Menopause is known to be associated with increased risk for meta-
bolic syndrome.14-18) Besides marked changes in hormonal levels, 
menopause is characterized by many other changes that could be 
linked to metabolic syndrome and can influence oxidative stress.16,19) 
Although a previous Korean study showed that the serum uric acid 
level had a positive linear association with arterial stiffness in men, this 
relationship was not found in women.2) Little is known about how se-
rum uric acid levels are related to the risk of increased arterial stiffness 
in postmenopausal women. Therefore, we examined the association 
between serum uric acid levels and arterial stiffness in postmenopaus-
al women.
METHODS
1. Study Design and Participants
This cross-sectional study was based on data obtained from the health 
promotion center of Gangnam Severance Hospital. We received the 
medical records of 966 participants (392 pre-menopausal women, 574 
postmenopausal women) who underwent medical examinations at a 
single center between October 2007 and July 2010. Because we de-
signed the study to investigate the association between serum uric 
acid levels and the risk for an elevated ba-PWV in postmenopausal 
women, we excluded pre-menopausal women. Subjects meeting any 
of the following criteria were excluded (n=281): subjects with any 
missing value; subjects with any overlapping values; and those with 
white blood cell (WBC) count ≥10,000/μL or high-sensitivity C-reac-
tive protein ≥3.0 mg/L (to rule out acute inflammatory disorders). Af-
ter excluding subjects, 293 participants were included in the final anal-
ysis. This study was approved by the institutional review board of Yon-
sei University College of Medicine (IRB number: 3-2017-0228), and in-
formed consent was obtained from each participant. Participants were 
asked about lifestyle behaviors, including cigarette smoking, alcohol 
consumption, and physical activity (more or less than three times per 
week), as well as whether they had been diagnosed with hypertension 
or diabetes. Participants were classified as non-smokers, ex-smokers, 
or current smokers. Subjects were classified into two groups according 
to alcohol intake (alcohol consumption >140 g/wk or ≤140 g/wk). 
Body mass index (BMI) was calculated as weight in kg divided by 
height in meters squared (kg/m2).
 Diabetes was defined as a self-reported history of the disorder or a 
fasting plasma glucose level ≥126 mg/dL. Hypertension was defined as 
a self-reported history of the disorder, systolic blood pressure ≥140 
mm Hg, or diastolic blood pressure ≥90 mm Hg.
 We designed two models to evaluate the adjusted odds ratio (OR). 
Model 1 was calculated with an unadjusted OR, and model 2 was ad-
justed for age, BMI, smoking status, alcohol intake, regular exercise, 
history of hypertension, history of diabetes, total cholesterol, resting 
heart rate, and neutrophil-lymphocyte ratio, all of which are known as 
conventional risk factors. Previous studies, including the study by Park 
et al.,13,20) showed that a higher resting heart rate and neutrophil-lym-
phocyte ratio were independently associated with arterial stiffness. 
Based on these previous studies, we designed model 2 to contain 
known confounding factors.
2. Brachial-Ankle Pulse Wave Velocity Measurement
An automatic waveform analyzer was used to measure PWV. This in-
strument simultaneously records venous blood pressure and arterial 
blood pressure at both brachial arteries and ankles while also per-
forming a phonocardiogram and electrocardiogram. Participants were 
examined in the supine position after 10 minutes of bed rest. Electro-
cardiogram electrodes were placed on both wrists, and a microphone 
for the phonogram was placed on the left edge of the sternum. Pneu-
monic cuffs were wrapped around both upper arms and ankles and 
connected to a plethysmographic sensor to determine the volume 
pulse waveform. Waveforms for the upper arm (brachial artery) and 
ankle (tibial artery) were stored for 10-second sample times with auto-
matic gain analysis and quality adjustment. Oscillometric pressure 
sensors were attached to the cuffs to measure blood pressure in the 
four extremities. The ba-PWVs were recorded using a semiconductor 
pressure sensor (1,200 Hz sample acquisition frequency) and calculat-
ed using the following equation: (La-Lb)/ΔTba. La and Lb were de-
fined as the distance from the aortic valve to the elbow and to the an-
kle, respectively. The distance from the suprasternal notch to the el-
bow (La) and from the suprasternal notch to the ankle (Lb) were cal-
culated as follows: La=0.2195×height of participant (cm)-2.0734 and 
Lb=0.8129×height of participant (cm)+12.328. The time interval be-
tween the arm and ankle distance (ΔTba) was defined as the pulse 
transit time between the brachial and tibial arterial pressure wave-
forms. La and Lb were estimated automatically based on the heights of 
the participants.
3. Statistical Analysis
Uric acid quartiles were categorized as follows: Q1≤3.8, Q2=3.9 to 4.4, 
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Q3=4.5 to 4.9, and Q4≥5.0 mg/dL. Demographic and biochemical 
characteristics of the study population according to uric acid quartiles 
were compared using a one-way analysis of variance for continuous 
variables and the chi-square test for categorical variables. Individuals 
were divided into two groups based on ba-PWV: a high group and a 
low group. A high ba-PWV was defined as a ba-PWV of more than 
1,450 cm/s.13) The ORs for high ba-PWV were calculated using multi-
variate logistic regression analysis after adjusting for confounding vari-
ables across uric acid quartiles. All analyses were conducted using 
IBM SPSS statistical software ver. 22.0 (IBM Corp., Armonk, NY, USA). 
All statistical tests were two-sided, and statistical significance was as-
sumed when P<0.05.
RESULTS
In this study, 293 postmenopausal women were divided into quartiles 
according to their uric acid levels. Characteristics of the study popula-
tion are shown in Table 1. BMI, systolic blood pressure, diastolic blood 
pressure, fasting plasma glucose level, triglyceride level, resting heart 
rate, and the WBC count, were highest in the fourth quartile. In the 
second serum uric acid quartile, the ba-PWV was the lowest (Q1, 1,474 
cm/s; Q2, 1,375 cm/s; Q3, 1,422 cm/s, Q4, 1,528 cm/s). We designated 
Q2 as the control group based on ba-PWV level.
 In multiple logistic regression model 1, the corresponding ORs (95% 
confidence intervals [CIs]) for high ba-PWV across uric acid quartiles 
1, 3, and 4 were 2.561 (1.261–5.202), 2.954 (1.454–6.002), and 4.170 
(2.086–8.337). Although the first quartile had a lower serum uric acid 
level than the second quartile, Q1 had a higher risk for ba-PWV than 
did Q2. Multivariate-adjusted ORs (95% CI) for the highest versus the 
lowest quartiles of uric acid were 4.375 (Q4, 1.923–9.949) and 2.642 
(Q1, 1.095–6.373) in model 2, respectively (Table 2).
DISCUSSION
In this cross-sectional study, we found that serum uric acid level quar-
tiles had a J-shaped association with arterial stiffness in Korean post-
menopausal women. Q2 (uric acid level, 3.9–4.4) had the lowest OR 
value for high ba-PWV across the uric acid quartiles, while the risk of 
arterial stiffness was greatest in Q4 (uric acid level ≥5.0). Interestingly, 
although the first quartile had a lower serum uric acid level than the 
second quartile, Q1 (uric acid level ≤3.8) had a higher risk for ba-PWV 
than did Q2 (uric acid level, 3.9–4.4). These results were similar after 
Table 1. Clinical and chemical characteristics of the study population according to uric acid quartile
Characteristic
Uric acid (mg/dL )
P-value
Q1 (≤3.8) Q2 (control, 3.9–4.4) Q3 (4.5–4.9) Q4 (≥5.0)
Number 70 76 69 78
Age (y) 58.7±7.3 57.9±6.8 57.7±6.0 58.5±6.1 0.781
Body mass index (kg/m2) 22.2±2.7 22.5±2.6 22.8±2.5 23.8±2.8 0.001
SBP (mm Hg) 124.1±17.9 118.8±21.1 123.3±17.3 124.5±16.6 0.200
DBP (mm Hg) 76.3±10.7 72.7±10.0 75.5±10.1 76.5±9.5 0.072
Fasting plasma glucose (mg/dL) 95.4±15.9 90.6±15.4 94.4±14.5 99.1±21.5 0.025
Total cholesterol (mg/dL) 191.1±32.0 204.9±36.9 202.4±40.2 199.5±39.7 0.139
Uric acid (mg/dL) 3.3±0.4 4.2±0.2 4.7±0.2 5.6±0.5 0.000
Brachial-ankle pulse wave velocity (cm/s) 1,474±260 1,375±222 1,422±167 1,528±275 0.001
White blood cell count (×109 cells/L) 4.9±1.3 4.8±1.3 5.2±1.5 5.9±1.4 0.000
Neutrophil-lymphocyte ratio 1.8±0.9 1.8±0.8 2.1±1.1 2.1±1.0 0.078
Heart rate (beats/min) 74.3±10.9 73.4±11.1 72.7±9.6 74.4±12.0 0.763
Hypertension* 24 (34.3) 16 (21.1) 17 (24.6) 27 (34.6) 0.162
Diabetes† 8 (11.4) 6 (7.9) 4 (5.8) 9 (11.5) 0.565
Current smoker 4 (5.7) 7 (9.2) 6 (8.7) 3 (3.8) 0.516
Alcohol ingestion‡ 2 (2.9) 0 0 0 0.093
Regular exercise§ 52 (74.3) 52 (68.4) 51 (73.9) 48 (61.5) 0.291
Values are presented as mean±standard deviation or number (%).
SBP, systolic blood pressure; DBP, diastolic blood pressure.
*Defined as a SBP ≥140 mm Hg, DBP ≥90 mm Hg, or a history of the disorder. †Defined as fasting plasma glucose level ≥126 mg/dL or a history of the disorder. ‡≥140 g 
alcohol consumption per week. §≥3 times per week.
Table 2. Odds ratios and 95% confidence intervals for brachial-ankle pulse wave 
velocity according to uric acid quartiles
Uric acid quartiles Odds ratio (95% confidence interval)
Model 1* Q1 2.561 (1.261–5.202)
Q2 (control) Reference
Q3 2.954 (1.454–6.002)
Q4 4.170 (2.086–8.337)
Model 2† Q1 2.642 (1.095–6.373)
Q2 (control) Reference
Q3 4.305 (1.798–10.307)
Q4 4.375 (1.923–9.949)
*Unadjusted. †Adjusted for age, body mass index, smoking status, alcohol intake, 
regular exercise, history of hypertension, history of diabetes, total cholesterol, resting 
heart rate, and neutrophil-lymphocyte ratio.
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adjusting for age, BMI, smoking status, alcohol intake, regular exercise, 
history of hypertension, history of diabetes, total cholesterol level, rest-
ing heart rate, and neutrophil-lymphocyte ratio. The observed rela-
tionship between the lowest serum uric acid level quartile and ba-
PWV in Korean postmenopausal women has several possible explana-
tions. First, uric acid can function as an antioxidant.1,4,21) Thus, an indi-
vidual with a low serum uric acid level may have weak antioxidant ca-
pacity, which could be associated with increased vascular inflamma-
tion and structural changes within the arterial walls.1,4,21) Additionally, 
Kanda et al.22) reported that low serum uric acid levels were associated 
with the loss of renal function. Based on this study, low serum uric 
acid levels could therefore increase systemic vascular inflamma-
tion.22-24) Menopause may be another reason for the observed findings, 
because menopause causes hormonal changes and is associated with 
metabolic disease and increased insulin resistance.14,15,17,19,25) For ex-
ample, estrogen is known to decrease inflammatory markers, and es-
trogen secretion changes during menopause.16) Therefore, menopause 
could result in the increased expression of inflammatory markers, and 
postmenopausal women may be more prone to have inflammation 
than are premenopausal women. Postmenopausal women with low 
serum uric acid levels may show poor resistance to vascular oxidative 
stress and therefore consequently display progressive arterial stiffness. 
Shin et al.2) examined 779 Korean adults and reported that serum uric 
acid level in the normal range had a positive association with arterial 
stiffness in men, but not in women. The serum uric acid quartiles in 
women had a linear association with the ba-PWV; however, after ad-
justing for several possible confounding factors, serum uric acid quar-
tiles were found to not be independently associated. There are several 
possible reasons for this discrepancy between the sexes. First, 234 
women were enrolled in the study, while less men were enrolled. Sec-
ond, postmenopausal women, which may have a reduced antioxidant 
capacity, were included in this study and could have accounted for 
this difference between sexes. However, in this study, we included an 
abnormal range in serum uric acid level in our analysis. In doing so, 
we found that serum uric acid level had a J-shaped association with 
arterial stiffness in postmenopausal women.
 We used a cut-off value of ba-PWV of 1,450 cm/s, because Park et 
al.,13) who had examined the association between resting heart rate 
and arterial stiffness in a previous study, showed that a ba-PWV value 
greater than 1,450 cm/s was a powerful predictor of cardiovascular 
disease.
 This study had some limitations. First, it was a cross-sectional study, 
and the study population was recruited at only one center. Second, we 
cannot exclude the possibility that subjects were taking diuretics or al-
lopurinol, both of which can strongly influence serum uric acid levels. 
Third, we did not examine and compare serum uric acid levels in Ko-
rean men and premenopausal women. Finally, we did not determine 
the mechanism underlying the interaction between uric acid and ba-
PWV.
 This is the first study to report an association between serum uric 
acid levels and ba-PWV in postmenopausal women in Korea. In the 
near future, additional studies should examine the effects of increasing 
serum uric acid levels in postmenopausal women.
 In conclusion, in this cross-sectional study, we found that the serum 
uric acid level has a J-shaped association with arterial stiffness in post-
menopausal women.
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